Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Not Everyone Can Go Public, But Biopharma IPOs Are Using Multiple Markets

Nov 15 2018

• By Mandy Jackson

Finance Watch

Related Content

Deal Watch, Licensing & Alliances: Amgen Places $66m Bet On Genetic Sequencing

Oct 19 2018

Sarepta Commits To Rapid, Thorough Pivotal Study For DMD Gene Therapy Based On Functional Improvements

Oct 04 2018

Finance Watch: Rough US Stock Market Doesn't Stop Biopharma IPOs As Six More Go Public

Oct 31 2018

Asia Deal Watch: Alvotech Signs On To Biosimilar Manufacturing JV In China

Oct 10 2018

Parallel Trade Adds Up As Abacus Prepares IPO

Oct 01 2018

Finance Watch: With The Year's Biggest IPO, CFO Says Allogene Is Ready To Go 'Full Throttle'

Oct 12 2018

Aimmune Gets $145m From Nestlé To Advance Food Allergy Immunotherapies

Nov 04 2016

Can Editas, BeiGene Offerings Redeem US IPO Class Of 2015?

Feb 04 2016

Emergings In Brief, May 2013

May 09 2014

Dsuvia Approval May Be Followed By New Opioid Review Paradigm At FDA

Nov 02 2018

Deal Watch: Neos Says ‘Thanks, No Thanks’ To Repeated PDL Offer

Nov 01 2017

Finance Watch: 2018 Biopharma VC Investment Could Beat 2017 One Quarter Ahead Of Schedule

Jul 16 2018

Aimmune Accelerates Commercial Planning For Peanut Allergy Drug

Feb 21 2018

Pipeline Watch: Phase III Top-Line Data With Givosiran, Soliris and Vascepa

Oct 01 2018

Finance Watch: Lots Of Money, Big And Small, Flowing Into Drug Development

May 10 2018

Deal Watch: Genentech Gets Down In The Dirt With Lodo Therapeutics

May 11 2018

Hong Kong Ushers in 'New Era' For Bioventures As Listing Rules Eased

May 02 2018

Finance Watch: Ascletis First Biotech To List Under New Hong Kong Rules, BeiGene Joins In

Aug 03 2018

Deal Watch, Focus On Acquisitions: Emergent Acquires PaxVax, Pair Of Commercialized Vaccines

Aug 14 2018

Sarepta Outlines A Fast Path Forward For Its DMD Gene Therapy

Jun 19 2018

Themis Bioscience Reaps Bill Gates' Backed CEPI Funding For Lassa Fever And MERS Vaccines

Mar 07 2018

Marinomed Biotechnologie GMBH

Jun 01 2009

Related Companies

Moderna, Inc.

Ascletis Pharma, Inc.

BeOne Medicines Ltd.

Hua Medicine (Shanghai) Ltd.

Innovent Biologics, Inc.

Themis Bioscience GmbH

Marinomed Biotech AG

Merck & Co., Inc.

Allogene Therapeutics Inc.

Centrexion Therapeutics Corporation

Synthorx, Inc.

Taiwan Liposome Company, Ltd.

DiaMedica Therapeutics Inc.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Henlius Biotech Co. Ltd.

Sarepta Therapeutics, Inc.

Lysogene SA

Myonexus Therapeutics, Inc.

Omeros Corporation

Nestle Health Science

Aimmune Therapeutics, Inc.

Clementia Pharmaceuticals, Inc.

Alaunos Therapeutics, Inc.

OvaScience, Inc.

Millendo Therapeutics, Inc.

Newron Pharmaceuticals S.p.A.

Talphera, Inc.

Neos Therapeutics, Inc.

Additional Topics

Asia Pacific Europe US States Financing Business Strategies Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window